Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02600897

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta, Georgia, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Missouri/Ellis Fischel Columbia, Missouri, United States
  • Washington University; Wash Uni. Sch. Of Med St Louis, Missouri, United States
View all 28 locations
View Trial Details
Completed

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

NCT00520767

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
Locations
  • Rocky Mountain Cancer Centers/Rocky Mountain Blood & Marrow Transplant Program Denver, Colorado, United States
  • Boston University Cancer Research Center Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
View Trial Details

Related conditions